Edwards Lifesciences Corporation

NYSE:EW

68.52 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Operating Activities:
Net Income 1,399.41,521.91,503.1823.41,046.9722.2583.6569.5494.9811.1391.7293.2236.7218229.1128.9113130.579.31.77955.7-11-27282
Depreciation & Amortization 144.9139.6134.8107.289.377.481.971.265.868.668.757.35856.558.755.654.856.856.255.745.640.4577484
Deferred Income Tax -272.1-254.5-41.4-49.412.1-27.317.8-37.4-95-71.10.18.1-0.6-11.2-4-23.5-5.67.1-13.80.85.3-13.8-3000
Stock Based Compensation 139.4126.8109.392.681.37161.656.949.948.347.442.13529.328.328.727.726.60000000
Change In Working Capital -526.3-421.4145.342.2-204.3-42.6234.266.164.4190.321.511.5-29.7-1.1-68.3-69.54.1-14.9-3.62.8-19.9-36.3-5-12-1
Accounts Receivables -141.2-84.1-112.4283.9-94.8-13-3.9-56.7-38.3-26.88.5-26.5-53.7-34.2-51.6-68.5-6.62.5-12.67.1-11-32000
Inventory -289-213.419-120.6-105.4-65.7-124-65.6-67.7-30.5-44.4-21.7-57-36.8-13.1-17.8-9-12.8-12.9-7.14.213.3-715-14
Accounts Payables 146-21.4195.2-84.5-63.5192.585.27429.4112.950.341.961.763.6-16.332.914-3.925.113-8.4-17.6000
Other Working Capital -242.1-102.543.5-36.659.4-156.4276.9114.4141134.77.117.819.36.312.7-16.15.7-0.7-3.2-10.2-4.702-2713
Other Non Cash Items 10.5105.8-11938.3154.1126.121.6-21.9-30.3-24.9-56.7-38.415.1-40.1-78.53316.224.718.7119.612.374.6834711
Operating Cash Flow 895.81,218.21,732.11,054.31,179.4926.81,000.7704.4549.71,022.3472.7373.8314.5251.4165.3153.2210.2230.8136.8180.6122.3120.6101137176
Investing Activities:
Investments In Property Plant And Equipment -266.3-264.8-329.8-407.3-278.4-241.7-175.5-217.4-106.5-93.7-110.1-127.7-90.6-63-64-78-62.5-59.4-48.5-42.5-37.9-40.7-38-46-42
Acquisitions Net -95.20329.8407.3-100.2-6.2-184.6-5.7-333.7-24.1-2.7-35.8-42.6-1.26469.6-3700-137.70-1900-7
Purchases Of Investments -105.5-778.9-1,892.4-861.7-603.1-471.9-1,347.4-1,074.9-1,318-2,131.2-824.6-593.2-645.6-7.3-7.4-1.3-57.3-1.80000000
Sales Maturities Of Investments 715.81,359.1529.2777409.9801.31,103.41,085.11,439.71,612.9526.4662.3362.12.213.7415.600000000
Other Investing Activites -75-63.1-359.3-446.4-24-4.8-43.11.22.43.1-1.73.93.97.833.827.56.725.521.33.1-25.4-8.634-290
Investing Cash Flow 173.8252.3-1,722.5-531.1-595.876.7-647.2-211.7-316.1-633-412.7-90.5-412.8-61.540.158.8-144.5-35.7-27.2-177.1-63.3-68.3-4-75-49
Financing Activities:
Debt Repayment -0.3-0.2-7-17-10-1,125.3-818.4-31.4-29.5-239-895.4-367.5-421.7-302.8-213.9-112.1000000000
Common Stock Issued 169.9146.4158.6140.5160.5147113.8103.387.2113.345.5100.159.592.166.763.838.733.526.230.536.613.7040
Common Stock Repurchased -879.6-1,727.1-512.8-625.4-263.3-795.5-763.3-662.3-280.1-300.9-496.9-344.1-303.4-200-95.5-306.5-130.9-145.9-53.5-59.1-49.4-30.8000
Dividends Paid 0000000000000000000000000
Other Financing Activities 168.9142.8163.5155.5157.71,360.6994.7575.495.2499.92,686.7862.91,056.5561.2280.2427-15.9-81.256.38.1-2.2-52.4-78-41-127
Financing Cash Flow -711-1,584.5-356.3-486.9-115.6-1,101.2-473.2-268.5-158.6-15334.9-155.6-135.2-103.9-91.8-134.1-108.1-193.629-20.5-15-69.5-78-37-127
Other Information:
Effect Of Forex Changes On Cash 16.819.213.9-20.5-3-6.57.9-12.5-10.4-2.914.6128.6-241.8-11.42.7-8.94.8-17.13.7130
Net Change In Cash 375.4-94.8-332.815.8465-104.2-111.8211.764.6233.4109.5139.7-224.962115.476.9-414.2129.7-12.226.9-13.520280
Cash At End Of Period 1,148772.6867.41,200.21,179.1714.1818.3930.1718.4653.8420.4310.9171.2396.1334.1218.7141.8182.8178.648.961.134.248280